These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29788900)

  • 1. Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics.
    Eldholm RS; Persson K; Barca ML; Knapskog AB; Cavallin L; Engedal K; Selbaek G; Skovlund E; Saltvedt I
    BMC Geriatr; 2018 May; 18(1):120. PubMed ID: 29788900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.
    Eldholm RS; Barca ML; Persson K; Knapskog AB; Kersten H; Engedal K; Selbæk G; Brækhus A; Skovlund E; Saltvedt I
    J Alzheimers Dis; 2018; 61(3):1221-1232. PubMed ID: 29254085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
    Bergland AK; Dalen I; Larsen AI; Aarsland D; Soennesyn H
    J Alzheimers Dis; 2017; 56(2):575-584. PubMed ID: 28035932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.
    Scott TM; Bhadelia RA; Qiu WQ; Folstein MF; Rosenberg IH
    J Alzheimers Dis; 2018; 65(1):293-302. PubMed ID: 30040728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter hyperintensities and imaging patterns of brain ageing in the general population.
    Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
    Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
    Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
    Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.
    Gouw AA; van der Flier WM; Fazekas F; van Straaten EC; Pantoni L; Poggesi A; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Scheltens P; Barkhof F;
    Stroke; 2008 May; 39(5):1414-20. PubMed ID: 18323505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline predictors of cognitive decline in patients with cerebral small vessel disease.
    Pavlovic AM; Pekmezovic T; Tomic G; Trajkovic JZ; Sternic N
    J Alzheimers Dis; 2014; 42 Suppl 3():S37-43. PubMed ID: 24898641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of dementia and associated risk factors in Japan: The Osaki-Tajiri Project.
    Meguro K; Ishii H; Kasuya M; Akanuma K; Meguro M; Kasai M; Lee E; Hashimoto R; Yamaguchi S; Asada T
    J Neurol Sci; 2007 Sep; 260(1-2):175-82. PubMed ID: 17553526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer's dementia.
    Huang CW; Tsai MH; Chen NC; Chen WH; Lu YT; Lui CC; Chang YT; Chang WN; Chang AY; Chang CC
    Thromb Haemost; 2015 Nov; 114(6):1230-40. PubMed ID: 26289958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of vascular risk factors on cognitive decline in patients with Alzheimer's disease.
    Blom K; Vaartjes I; Peters SA; Koek HL
    Maturitas; 2014 Sep; 79(1):96-9. PubMed ID: 25059438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia.
    Hazen J; Vistnes M; Barca ML; Eldholm RS; Persson K; Brækhus A; Saltvedt I; Selbæk G; Engedal K; Knapskog AB
    Alzheimer Dis Assoc Disord; 2020; 34(1):47-53. PubMed ID: 31414991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathological basis of magnetic resonance images in aging and dementia.
    Jagust WJ; Zheng L; Harvey DJ; Mack WJ; Vinters HV; Weiner MW; Ellis WG; Zarow C; Mungas D; Reed BR; Kramer JH; Schuff N; DeCarli C; Chui HC
    Ann Neurol; 2008 Jan; 63(1):72-80. PubMed ID: 18157909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular risk factors and Alzheimer's disease.
    Cechetto DF; Hachinski V; Whitehead SN
    Expert Rev Neurother; 2008 May; 8(5):743-50. PubMed ID: 18457531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.
    Pelcher I; Puzo C; Tripodis Y; Aparicio HJ; Steinberg EG; Phelps A; Martin B; Palmisano JN; Vassey E; Lindbergh C; McKee AC; Stein TD; Killiany RJ; Au R; Kowall NW; Stern RA; Mez J; Alosco ML
    J Alzheimers Dis; 2020; 78(4):1393-1408. PubMed ID: 33164933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between blood pressure and Alzheimer disease measured up to 27 years prior to diagnosis: the HUNT Study.
    Gabin JM; Tambs K; Saltvedt I; Sund E; Holmen J
    Alzheimers Res Ther; 2017 May; 9(1):37. PubMed ID: 28569205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.